SCHEMBL29472011

SCHEMBL29472011

Nc1nc(Cl)nnc1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16826658 1.00
SCHEMBL16826867 0.77
SCHEMBL16603576 0.72
SCHEMBL29558043 0.71
SCHEMBL11837238 0.70 ALDH1A1 (0.39)
SCHEMBL10414347 0.67 ALDH1A1 (0.43)
SCHEMBL5957149 0.67 CYP1A2 (0.34)
SCHEMBL1732884 0.65 ALDH1A1 (0.37)
SCHEMBL18562098 0.65
SCHEMBL1182747 0.65 ALDH1A1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114315796-B Compounds used as HPK1 kinase inhibitor, preparation method and application thereof 中国药科大学 2024-03-26 CN disclosed
CN-109415352-B 3-amino-1, 2, 4-triazine derivatives and their use for controlling unwanted plant growth 拜耳作物科学股份公司 2022-04-26 CN disclosed
CN-114315796-A Compound used as HPK1 kinase inhibitor and preparation method and application thereof 中国药科大学 2022-04-12 CN disclosed
CN-114173772-A Inhibitors of CD40-CD154 binding 托尼克斯医药控股公司 2022-03-11 CN disclosed
EP-3952853-A1 INHIBITORS OF CD40-CD154 BINDING Tonix Pharmaceuticals Holding Corp. (US) 2022-02-16 EP disclosed